Oxford researchers develop calculator to assess statin muscle disorder risk

Scientists at the University of Oxford have developed a predictive calculator that estimates an individual’s risk of serious muscle disorders—such as rhabdomyolysis—associated with statin therapy. In a recent analysis, the tool was applied to a large cohort of patients eligible for statins and found that over 98 % of them fall into the low‑risk category for these rare complications, challenging widespread concerns about statin side effects.

The study also highlighted a significant gap in statin use: most patients who qualify for the medication are not receiving it, potentially leaving them vulnerable to preventable heart attacks and strokes. By providing a personalized risk assessment, the calculator aims to help clinicians and patients make more informed decisions about statin therapy, balancing the benefits of cardiovascular protection against the possibility of muscle‑related adverse events.

Overall, the Oxford team’s findings suggest that statins remain a safe and effective option for the vast majority of eligible individuals, while underscoring the need for better patient engagement to improve adherence to proven heart‑health interventions.